Our results reveal that pharmacologic or genetic PRMT5 inhibition blocks the expression of SNAIL, TWIST, and ZEB1 and almost completely blocks metastases in aggressive in vivo tumor models. This evidence concerns the gene TWIST1 and neoplasm.